PSC
CELG

Prentiss Smith & Co’s Celgene Corp CELG Stock Holding History

Prentiss Smith & Co’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-8,095
Closed -$804K – 67
2019
Q3 		$804K Hold
8,095
– – 0.54% 32
2019
Q2 		$748K Sell
8,095
-70
-0.9% -$6.65K 0.49% 34
2019
Q1 		$770K Sell
8,165
-1,091
-12% -$95.4K 0.49% 31
2018
Q4 		$593K Buy
9,256
+1,112
+14% +$82.1K 0.37% 35
2018
Q3 		$729K Sell
8,144
-374
-4% -$33.1K 0.42% 31
2018
Q2 		$676K Sell
8,518
-2,055
-19% -$171K 0.41% 32
2018
Q1 		$943K Buy
10,573
+338
+3% +$32.4K 0.49% 34
2017
Q4 		$1.07M Buy
10,235
+17
+0.2% +$1.92K 0.52% 31
2017
Q3 		$1.49M Sell
10,218
-262
-3% -$35.7K 0.86% 21
2017
Q2 		$1.36M Sell
10,480
-800
-7% -$98K 0.71% 28
2017
Q1 		$1.4M Buy
11,280
+148
+1% +$17.7K 0.8% 25
2016
Q4 		$1.29M Buy
11,132
+406
+4% +$45.2K 0.79% 26
2016
Q3 		$1.12M Hold
10,726
– – 0.63% 32
2016
Q2 		$1.06M Sell
10,726
-748
-7% -$77.4K 0.6% 33
2016
Q1 		$1.15M Sell
11,474
-100
-0.9% -$10.3K 0.66% 31
2015
Q4 		$1.39M Buy
11,574
+3,385
+41% +$392K 0.73% 29
2015
Q3 		$886K Sell
8,189
-5,357
-40% -$665K 0.49% 35
2015
Q2 		$1.57M Sell
13,546
-26
-0.2% -$2.97K 0.77% 30
2015
Q1 		$1.56M Sell
13,572
-1,910
-12% -$228K 0.75% 29
2014
Q4 		$1.73M Buy
15,482
+1,128
+8% +$119K 0.8% 28
2014
Q3 		$1.36M Sell
14,354
-1,150
-7% -$104K 0.68% 32
2014
Q2 		$1.33M Buy
15,504
+416
+3% +$31.6K 0.68% 30
2014
Q1 		$1.05M Sell
15,088
-2,310
-13% -$183K 0.56% 34
2013
Q4 		$1.47M Sell
17,398
-4,950
-22% -$392K 0.77% 26
2013
Q3 		$1.72M Sell
22,348
-1,300
-5% -$91.1K 0.89% 24
2013
Q2 		$1.38M Buy
+23,648
New +$1.42M 0.72% 38

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Prentiss Smith & Co's CELG Position: Q4 2019 in Review

Prentiss Smith & Co sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 8,095 shares — an estimated $804K sold.

Prentiss Smith & Co first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $1.73M in Q4 2014. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Prentiss Smith & Co reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Prentiss Smith & Co sold 8,095 Celgene Corp shares in Q4 2019, an estimated $804K.
  • Prentiss Smith & Co first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Prentiss Smith & Co's Celgene Corp position peaked at $1.73M in Q4 2014.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Prentiss Smith & Co's 13F filing for Q4 2019, filed 21 Jan 2020.